News|Articles|December 1, 2013
Reasons for Clinical Failures by Phase
Tufts
Advertisement
The Tufts Center for the Study of Drug Development (Tufts CSDD) recently analyzed the reasons for clinical failures for 410 drugs that entered human testing between 2000 and 2009.
The results of this analysis show that commercial viability—as opposed to safety—is the leading cause of Phase I failures. Commercial viability played a diminishing role in the reasons for drugs failing in later clinical phases. Safety issues accounted for one-third of all drugs that failed in Phase I and Phase III studies; and for 17% of all Phase II failures.
Efficacy issues dominated both Phase II and III accounting for more than half of the total drugs that failed (54% and 52% respectively). Tufts CSDD researchers conclude that the ever-changing commercial landscape combined with insights gleaned from later-stage studies conducted among larger patient populations present ongoing drug development risk-dynamics that are difficult for sponsors to anticipate and manage.
—Tufts Center for the Study of Drug Development, https://csdd.tufts.edu/ .
Articles in this issue
almost 12 years ago
On Trial—Europe's Response to Antibiotic Research Gapalmost 12 years ago
Clinical Trial Design Automationalmost 12 years ago
Clinical Supply Issues Challenge Sponsors and Patientsalmost 12 years ago
Reasons for Clinical Failures by Phasealmost 12 years ago
Act Coveralmost 12 years ago
Clearing the Way for the Internet of Thingsalmost 12 years ago
Developing a Successful Peer-to-Peer Mentoring Programalmost 12 years ago
Clinical Technologiesalmost 12 years ago
Jury's Still Out on How Best to Handle Trial Dataalmost 12 years ago
Exciting Changes for Applied Clinical Trials in 2014almost 12 years ago
Training and Educationalmost 12 years ago
Virtual CRA Meetings: Promoting Discussion, not Silencealmost 12 years ago
Events Calendaralmost 12 years ago
Applied Clinical Trials Digital Edition - December 2013/January 2014Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How AI Can Help Physicians Identify Eligible Trials Faster
September 5th 2025
Advertisement
Advertisement